Original Research Online Publishing Date: | ||||||||||||
Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study Vidhya Sreekumar, Dayanidhi Meher, Siddhartha Goutam, Manas Ranjan Mishra, Ratikanta Tripathy, Jyotirmoyee Jena.
|
How to Cite this Article |
Pubmed Style Sreekumar V, Meher D, Goutam S, Mishra MR, Tripathy R, Jena J. Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. Natl J Physiol Pharm Pharmacol. 2021; 11(5): 514-518. doi:10.5455/njppp.2021.11.01006202112012021 Web Style Sreekumar V, Meher D, Goutam S, Mishra MR, Tripathy R, Jena J. Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. https://www.njppp.com/?mno=38973 [Access: March 14, 2024]. doi:10.5455/njppp.2021.11.01006202112012021 AMA (American Medical Association) Style Sreekumar V, Meher D, Goutam S, Mishra MR, Tripathy R, Jena J. Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. Natl J Physiol Pharm Pharmacol. 2021; 11(5): 514-518. doi:10.5455/njppp.2021.11.01006202112012021 Vancouver/ICMJE Style Sreekumar V, Meher D, Goutam S, Mishra MR, Tripathy R, Jena J. Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. Natl J Physiol Pharm Pharmacol. (2021), [cited March 14, 2024]; 11(5): 514-518. doi:10.5455/njppp.2021.11.01006202112012021 Harvard Style Sreekumar, V., Meher, . D., Goutam, . S., Mishra, . M. R., Tripathy, . R. & Jena, . J. (2021) Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. Natl J Physiol Pharm Pharmacol, 11 (5), 514-518. doi:10.5455/njppp.2021.11.01006202112012021 Turabian Style Sreekumar, Vidhya, Dayanidhi Meher, Siddhartha Goutam, Manas Ranjan Mishra, Ratikanta Tripathy, and Jyotirmoyee Jena. 2021. Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (5), 514-518. doi:10.5455/njppp.2021.11.01006202112012021 Chicago Style Sreekumar, Vidhya, Dayanidhi Meher, Siddhartha Goutam, Manas Ranjan Mishra, Ratikanta Tripathy, and Jyotirmoyee Jena. "Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 514-518. doi:10.5455/njppp.2021.11.01006202112012021 MLA (The Modern Language Association) Style Sreekumar, Vidhya, Dayanidhi Meher, Siddhartha Goutam, Manas Ranjan Mishra, Ratikanta Tripathy, and Jyotirmoyee Jena. "Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study." National Journal of Physiology, Pharmacy and Pharmacology 11.5 (2021), 514-518. Print. doi:10.5455/njppp.2021.11.01006202112012021 APA (American Psychological Association) Style Sreekumar, V., Meher, . D., Goutam, . S., Mishra, . M. R., Tripathy, . R. & Jena, . J. (2021) Effect of saroglitazar and pioglitazone on lipid parameters and glycemic profile in type II diabetes mellitus patients with dyslipidemia: An observational open-label study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (5), 514-518. doi:10.5455/njppp.2021.11.01006202112012021 |